Response Genetics Financial Statements
Response Genetics Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
Response Genetics Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 7.8 | 6.0 | 7.0 |
| Gross Profit ($ mil.) | 3.7 | 3.6 | 5.2 |
| Operating Income ($ mil.) | (5.5) | (1.6) | 1.9 |
| Total Net Income ($ mil.) | (5.1) | (1.4) | 1.9 |
| Diluted EPS (Net Income) | (0.78) | (0.84) | 0.31 |
Response Genetics Stock Quote & Chart
08/29/08 14:02:36 EST •
NASDAQ •
3.40
•
 0.0000
•
0.0000 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Response Genetics Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 4.05 | 3.75 | 1.56 |
| Price/Earnings Ratio | -- | 16.34 | 15.82 |
| Price/Book Ratio | 2.38 | 2.92 | 1.52 |
| Price/Cash Flow Ratio | -- | 13.17 | 9.88 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Response Genetics Financial Ratios
Response Genetics Competitive Intelligence
| Clinical Data | Genomic Health | Quest Diagnostics | |
|---|---|---|---|
| Annual Sales ($ mil.) | 63.7 | 64.0 | 6,704.9 |
| Employees | 459 | 288 | 43,500 |
| Market Cap ($ mil.) | -- | 689.7 | 10,592.8 |
Competitive Landscape
